Women's Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Breast Cancer
Pivotal breast cancer study launched
June 2nd, 2005
Predictive medicine company IMI International Medical Innovations, Inc., (IMI; IME) is launching a pivotal clinical study for its non-invasive breast cancer detection test, in collaboration with the University of Louisville, in Louisville, Kentucky, the company announced. IMI's test identifies a cancer-associated sugar in a sample of nipple-aspirate fluid, which is painlessly derived from the mammary ducts and expressed through the nipple. Breast cancer is the most common cancer among women, other than skin cancer. About 211,240 women in the U.S. can expect to be diagnosed with invasive breast cancer in 2005, and about 40,410 women will die from the...
Source: Women's Health Weekly (2005-06-02)
|
